3580sek
0,8 %
Date:2025-04-04Time:18:00:00Latest report:Q4-2024List:First NorthTicker:FLUO
Market Cap:488 msekEnterprise Value:459 msekNet Sales:- mdkkEarnings:-29,0 mdkkEmployees:0ISIN:DK0061123312

Ratios

10-year key figure history for FluoGuide turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for FluoGuide with index and moving average MA50 and MA200.

Stockprice:35,80
MA50:43,65
MA200:41,26
Price/MA200:-13,2 %
RSI (14):35,6
Price/MA50:-18,0 %

Description

FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.

Medical Equipment